# Tumor Bed Dose Delivery Using A Breast Specific Radiosurgery Device, The Gammapod: (A Clinical Feasibility Study)

> **NCT02627313** · NA · UNKNOWN · sponsor: **Ottawa Hospital Research Institute** · enrollment: 20 (estimated)

## Conditions studied

- Breast Neoplasms

## Interventions

- **DEVICE:** GammaPod Tumour Bed Boost

## Key facts

- **NCT ID:** NCT02627313
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01
- **Primary completion:** 2021-12
- **Final completion:** 2022-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2020-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02627313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02627313, "Tumor Bed Dose Delivery Using A Breast Specific Radiosurgery Device, The Gammapod: (A Clinical Feasibility Study)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02627313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*